LEADER 01708nam  2200421 a 450 
001 9910695785803321
005 20070320112430.0
035   $a(CKB)5470000002371919
035   $a(OCoLC)86076826
035   $a(EXLCZ)995470000002371919
100   $a20070320d2006      ua             0
101 0 $aeng
135   $aurmn|---|||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aEnd-stage renal disease$b[electronic resource] $eMedicare payments for all ESRD services, including injectable drugs, should be bundled : testimony before the Committee on Ways and Means, House of Representatives /$fstatement of David M. Walker
210  1$a[Washington, D.C.] :$cU.S. Government Accountability Office,$d[2006]
215   $a5 pages $cdigital, PDF file
225 1 $aTestimony ;$vGAO-07-266 T
300   $aTitle from title screen (viewed on Mar. 13, 2007).
300   $a"For release ... December 6, 2006."
300   $aPaper version available from: U.S. Government Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548.
320   $aIncludes bibliographical references.
517   $aEnd-stage renal disease 
606   $aMedicare$xEconomic aspects
606   $aChronic renal failure
615  0$aMedicare$xEconomic aspects.
615  0$aChronic renal failure.
700   $aWalker$b David M$g(David Michael),$f1951-$01380682
712 02$aUnited States.$bCongress.$bHouse.$bCommittee on Ways and Means.
712 02$aUnited States.$bGovernment Accountability Office.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910695785803321
996   $aEnd-stage renal disease$93449621
997   $aUNINA